Precision Biosciences DTIL
NASDAQ DTIL
$6.74 +0.03 (+0.45%)
As of: Oct 22, 2026 · 1:12 PM EDT

Precision Biosciences (DTIL) Notes Payables (2019)

Updated

Precision Biosciences (DTIL) reported Notes Payables of $52.44 million for fiscal Q1 2019 (quarter ended Mar 31, 2019).

Analysis

Precision Biosciences (DTIL) Notes Payables (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn
10 Precision Biosciences 173.76 Mn -175.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 52.44 Mn
API Access

Precision Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=DTIL&period=max&api_key=YOUR_API_KEY